1. Home
  2. DNA vs MTLS Comparison

DNA vs MTLS Comparison

Compare DNA & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$7.84

Market Cap

458.6M

Sector

Health Care

ML Signal

N/A

Logo Materialise NV

MTLS

Materialise NV

N/A

Current Price

$7.71

Market Cap

431.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DNA
MTLS
Founded
2008
1990
Country
United States
Belgium
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
458.6M
431.6M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
DNA
MTLS
Price
$7.84
$7.71
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
1.0M
142.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
46.49
N/A
EPS
N/A
N/A
Revenue
$170,155,000.00
N/A
Revenue This Year
N/A
$6.38
Revenue Next Year
N/A
$6.45
P/E Ratio
N/A
$61.39
Revenue Growth
N/A
N/A
52 Week Low
$5.37
$4.78
52 Week High
$17.58
$7.72

Technical Indicators

Market Signals
Indicator
DNA
MTLS
Relative Strength Index (RSI) 49.32 66.20
Support Level $6.38 $6.37
Resistance Level $7.70 N/A
Average True Range (ATR) 0.33 0.27
MACD 0.06 0.05
Stochastic Oscillator 70.33 95.76

Price Performance

Historical Comparison
DNA
MTLS

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About MTLS Materialise NV

Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.

Share on Social Networks: